Zomacton 4mg (Somatropin E.P Vials) 4mg

Zomacton 4mg, containing Somatropin E.P, is a human growth hormone therapy used for growth hormone deficiency. This injectable vial provides 4mg of somatropin for subcutaneous use. Store between 2-8°C to maintain potency and efficacy. Suitable for adults and children with growth-related conditions.

Strength

4mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Ferring Pharmaceuticals Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zomacton 4mg is used to treat growth hormone deficiency in adults and children, supporting normal growth and development. It may also address conditions like Turner syndrome or chronic kidney disease-related growth issues. Patients often ask, 'what is Zomacton 4mg used for' to understand its role in hormone replacement therapy.

Side Effects

Users may experience improved energy levels and muscle tone as common effects of somatropin therapy. Some report enhanced physical performance and faster recovery after exercise. These effects vary by individual and are not guaranteed for everyone.

Precautions & Warnings

Store Zomacton 4mg vials refrigerated between 2-8°C to preserve potency. Avoid freezing or exposure to direct sunlight. Always check the solution for particles or discoloration before use. Consult a healthcare provider if you notice any unusual reactions.

Avoid Interactions

Zomacton 4mg may interact with corticosteroids, thyroid hormones, or insulin, potentially altering their effects. Alcohol and tobacco use can reduce the therapy's effectiveness. Always disclose all medications to your doctor before starting somatropin treatment.

References

Frequently Asked Questions

Zomacton 4mg vials should be kept refrigerated between 2-8°C. Avoid freezing and protect from light to maintain stability.

Zomacton 4mg is not approved for weight loss. It is prescribed for growth hormone deficiency and related conditions under medical supervision.

Common side effects may include injection site reactions, headaches, or joint pain. Report persistent issues to a healthcare provider.

Zomacton 4mg is prescribed for children with growth hormone deficiency or specific growth-related conditions. Dosage is determined by a doctor.

Results vary by individual. Some may notice changes within months, while others may take longer. Regular monitoring is required.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.